Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    musculoskeletal

    Juvenile idiopathic arthritis

    Also known as: JIA, Juvenile rheumatoid arthritis (historical term), Juvenile chronic arthritis (historical term)

    Juvenile idiopathic arthritis (JIA) encompasses a heterogeneous group of inflammatory arthritides with onset prior to 16 years of age, persisting for at least six weeks, diagnosed after other causes are excluded. Paediatric rheumatological management prioritises controlling inflammation, preserving articular integrity and growth, and surveillance for extra-articular manifestations such as uveitis. Traditional Chinese Medicine (TCM) constructs serve as an adjunctive framework for symptomatic management rather than a diagnostic tool for disease activity or a substitute for disease-modifying anti-rheumatic drugs (DMARDs). Although mechanistic reviews regarding acupuncture exist, current evidence provides insufficient data to establish robust efficacy or safety profiles in paediatric populations. A meta-analysis indicated potential benefits from the adjunctive use of total glucosides of paeony, though this does not validate the clinical application of complex botanical formulas. Pattern identifications herein represent traditional clinical typologies rather than evidence-based protocols for specific JIA subtypes.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Facilitate consistent, low-impact physical activity adhering to established rheumatological and physiotherapeutic protocols, with appropriate modifications during acute flares.
    • •Ensure adherence to stable sleep hygiene practices and maintain comprehensive documentation regarding the duration of morning stiffness, nocturnal waking, and levels of fatigue.
    • •Prioritise nutritional adequacy; clinical review is required for anorexia, weight fluctuations, or growth retardation. Avoid exclusionary dietary interventions unless clinically indicated.
    • •Coordinate necessary educational accommodations, ensure strict pharmacological adherence, and maintain the schedule for ophthalmological screenings and vaccinations in consultation with the multidisciplinary team.

    Cautions & Contraindications

    See sources
    • •Do not stop or reduce methotrexate, biologics, corticosteroids or other prescribed care because symptoms temporarily improve with adjunctive treatment. The supplied case highlights serious outcomes associated with delayed and interrupted treatment, without proving a single causal pathway.[]
    • •Defer needling through infected skin or an acutely hot, swollen joint; seek medical assessment first. Immunosuppression, suspected infection, significant neutropenia, thrombocytopenia or abnormal bleeding require treating-team clearance. These are general procedural precautions, not safety thresholds established by the supplied review.[,]
    • •Do not extrapolate the paeony-extract meta-analysis to whole-herb formulas or claim protection from medicine toxicity. Its abstract does not establish product interchangeability, long-term paediatric safety or formula-specific interactions; all proposed herbs need rheumatology and pharmacist review.[]

    When to reassess or seek care again

    See sources

    Agree baseline measures with the child and caregiver: age-appropriate pain score, morning-stiffness minutes, night waking, school participation and a specific functional task. Review after 2–4 weeks of any adjunctive trial, sooner for deterioration. Stop or revise adjunctive care if adverse effects occur or no meaningful functional benefit is apparent. Increasing swelling, loss of movement, systemic symptoms or reduced participation triggers rheumatology review rather than simply adding sessions or herbs. Continue specialist disease-activity monitoring independently of pain scores; the supplied quality-of-life record has no abstract from which to derive responder thresholds.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. The Journal of rheumatology · 2026
    2. Frontiers in pediatrics · 2026
    3. Frontiers in immunology · 2025
    4. Case reports in rheumatology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.